Charles River Laboratories International (CRL) Operating Expenses (2009 - 2025)

Charles River Laboratories International's Operating Expenses history runs 17 years deep, the most recent figure standing at $196.1 million for Q4 2025.

• In Q4 2025, Operating Expenses changed 0.22% year-over-year to $196.1 million; the TTM figure through Dec 2025 stood at $743.1 million (down 1.06% YoY), while the FY2025 annual figure was $743.1 million, down 1.06% from the prior year.
• Operating Expenses was $196.1 million for Q4 2025 at Charles River Laboratories International, up from $177.6 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $199.8 million in Q3 2023 to a low of $131.7 million in Q2 2022.
• Historically, Operating Expenses has averaged $176.3 million across 5 years, with a median of $177.7 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Operating Expenses retreated 23.2% in 2022, then jumped 51.66% in 2023.
• A 5-year view of Operating Expenses shows it stood at $144.1 million in 2021, then surged by 38.53% to $199.6 million in 2022, then declined by 1.25% to $197.1 million in 2023, then slipped by 0.73% to $195.7 million in 2024, then grew by 0.22% to $196.1 million in 2025.
• The last three Operating Expenses figures came in at $196.1 million (Q4 2025), $177.6 million (Q3 2025), and $191.5 million (Q2 2025), per Business Quant data.